Title | Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. |
Publication Type | Journal Article |
Year of Publication | 2010 |
Authors | Butler JM, Nolan DJ, Vertes EL, Varnum-Finney B, Kobayashi H, Hooper AT, Seandel M, Shido K, White IA, Kobayashi M, Witte L, May C, Shawber C, Kimura Y, Kitajewski J, Rosenwaks Z, Bernstein ID, Rafii S |
Journal | Cell Stem Cell |
Volume | 6 |
Issue | 3 |
Pagination | 251-64 |
Date Published | 2010 Mar 05 |
ISSN | 1875-9777 |
Keywords | Animals, Cell Communication, Cell Lineage, Cell Proliferation, Cells, Cultured, Coculture Techniques, Culture Media, Conditioned, Endothelial Cells, Hematopoietic Stem Cells, Ligands, Mice, Mice, Knockout, Receptor, Notch1, Receptor, Notch2, Signal Transduction |
Abstract | <p>Bone marrow endothelial cells (ECs) are essential for reconstitution of hematopoiesis, but their role in self-renewal of long-term hematopoietic stem cells (LT-HSCs) is unknown. We have developed angiogenic models to demonstrate that EC-derived angiocrine growth factors support in vitro self-renewal and in vivo repopulation of authentic LT-HSCs. In serum/cytokine-free cocultures, ECs, through direct cellular contact, stimulated incremental expansion of repopulating CD34(-)Flt3(-)cKit(+)Lineage(-)Sca1(+) LT-HSCs, which retained their self-renewal ability, as determined by single-cell and serial transplantation assays. Angiocrine expression of Notch ligands by ECs promoted proliferation and prevented exhaustion of LT-HSCs derived from wild-type, but not Notch1/Notch2-deficient, mice. In transgenic notch-reporter (TNR.Gfp) mice, regenerating TNR.Gfp(+) LT-HSCs were detected in cellular contact with sinusoidal ECs. Interference with angiocrine, but not perfusion, function of SECs impaired repopulation of TNR.Gfp(+) LT-HSCs. ECs establish an instructive vascular niche for clinical-scale expansion of LT-HSCs and a cellular platform to identify stem cell-active trophogens.</p> |
DOI | 10.1016/j.stem.2010.02.001 |
Alternate Journal | Cell Stem Cell |
PubMed ID | 20207228 |
PubMed Central ID | PMC2866527 |
Grant List | RC1 AI080309-01 / AI / NIAID NIH HHS / United States P01 HL059312-090006 / HL / NHLBI NIH HHS / United States R01 HL097797-03 / HL / NHLBI NIH HHS / United States P50 HL084936 / HL / NHLBI NIH HHS / United States P01 HL059312-100006 / HL / NHLBI NIH HHS / United States R01 HL097797-01 / HL / NHLBI NIH HHS / United States U01 HL066952-020002 / HL / NHLBI NIH HHS / United States RC1 AI080309 / AI / NIAID NIH HHS / United States P01 HL059312 / HL / NHLBI NIH HHS / United States U01 HL066952-040002 / HL / NHLBI NIH HHS / United States P01 HL059312-080006 / HL / NHLBI NIH HHS / United States HL075234 / HL / NHLBI NIH HHS / United States R21 HL083222-01 / HL / NHLBI NIH HHS / United States U01 HL066952 / HL / NHLBI NIH HHS / United States U01 HL066952-030002 / HL / NHLBI NIH HHS / United States P50 HL084936-010003 / HL / NHLBI NIH HHS / United States R21 HL083222-02 / HL / NHLBI NIH HHS / United States P01 HL067839 / HL / NHLBI NIH HHS / United States P50 HL084936-030003 / HL / NHLBI NIH HHS / United States R01 HL097797-02 / HL / NHLBI NIH HHS / United States R01 HL097797 / HL / NHLBI NIH HHS / United States P50 HL084936-020003 / HL / NHLBI NIH HHS / United States P01 HL059312-060006 / HL / NHLBI NIH HHS / United States P01 HL084205 / HL / NHLBI NIH HHS / United States HL097797 / HL / NHLBI NIH HHS / United States P01 HL067839-050004 / HL / NHLBI NIH HHS / United States P01 HL059312-070006 / HL / NHLBI NIH HHS / United States P50 HL084936-040003 / HL / NHLBI NIH HHS / United States U01 HL066952-050002 / HL / NHLBI NIH HHS / United States U01 HL066952-010002 / HL / NHLBI NIH HHS / United States R01 CA136673 / CA / NCI NIH HHS / United States / HHMI / Howard Hughes Medical Institute / United States P01 HL067839-040004 / HL / NHLBI NIH HHS / United States R21 HL083222 / HL / NHLBI NIH HHS / United States |